相关实验视频

Updated: Aug 16, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

基于指蛋白质的预后签名预测了肺腺癌的存活率

Lihui Yu1, Yahui Zhou2, Jingyu Chen3

  • 1Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.

Cancers
|July 12, 2025
PubMed
概括

这项研究确定了21种指蛋白 (ZNF) 作为肺腺癌 (LUAD) 存活的关键预测因素. 使用这些ZNF开发的风险评分模型可以区分高风险和低风险患者,有助于治疗策略.

关键词:
生物标志物生物标志物基因签名 基因签名 基因签名肺部腺癌的癌症.瘤免疫的微环境指蛋白质 是一种指蛋白质.

更多相关视频

Digital Analysis of Immunostaining of ZW10 Interacting Protein in Human Lung Tissues07:40

Digital Analysis of Immunostaining of ZW10 Interacting Protein in Human Lung Tissues

Published on: May 1, 2019

5.5K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...